硕腾
ZTS143.500USD
+2.400+1.70%
收盘 09/26, 16:00（美东）报价延迟15分钟
63.71B总市值
24.39市盈率 TTM
关于 硕腾 公司
硕腾. 是一家全球性动物保健公司。该公司专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物保健的发现、开发、制造和商业化。该公司通过两个部门运营：美国和国际部门。在每个运营部门中，该公司为伴侣动物和牲畜客户提供多样化的产品组合，包括杀虫剂、疫苗、皮肤病学、抗感染药、止痛药和镇静剂、其他药物和动物健康诊断。该公司直接在北美、欧洲、非洲、亚洲、澳大利亚和南美洲的约 45 个国家/地区销售其产品。该公司致力于将产品商业化，涉及八个核心物种：狗、猫和马（统称为伴侣动物）以及牛、家禽、猪、鱼和羊（统称为牲畜）。
公司简介
公司代码ZTS
公司名称Zoetis Inc
上市日期Feb 01, 2013
CEOMs. Kristin C. Peck
员工数量13800
证券类型Ordinary Share
年结日Feb 01
公司地址10 Sylvan Way
城市PARSIPPANY
上市交易所NYSE Consolidated
国家United States of America
邮编07054
电话19738227000
网址https://www.zoetis.com/
公司代码ZTS
上市日期Feb 01, 2013
CEOMs. Kristin C. Peck
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Mr. Robert J. Polzer, Ph.D.
Mr. Robert J. Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
2.82K
+51.75%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Parasiticides
562.00M
25.32%
Vaccines
447.00M
20.14%
Dermatology
390.00M
17.57%
Anti-infectives
249.00M
11.22%
Pain and sedation
210.00M
9.46%
其他
362.00M
16.31%
地区USD
名称
营收
占比
United States
1.18B
53.29%
Other emerging markets
248.00M
11.17%
Other Developed
133.00M
5.99%
Brazil
88.00M
3.96%
United Kingdom
77.00M
3.47%
其他
491.00M
22.12%
业务
地区
业务USD
名称
营收
占比
Parasiticides
562.00M
25.32%
Vaccines
447.00M
20.14%
Dermatology
390.00M
17.57%
Anti-infectives
249.00M
11.22%
Pain and sedation
210.00M
9.46%
其他
362.00M
16.31%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.11%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.80%
Geode Capital Management, L.L.C.
2.50%
其他
74.73%
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
5.11%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.80%
Geode Capital Management, L.L.C.
2.50%
其他
74.73%
股东类型
持股股东
占比
Investment Advisor
49.46%
Investment Advisor/Hedge Fund
31.77%
Research Firm
5.03%
Insurance Company
3.90%
Bank and Trust
2.57%
Pension Fund
2.35%
Hedge Fund
2.17%
Sovereign Wealth Fund
1.25%
Family Office
0.15%
其他
1.36%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
2023Q1
2913
436.42M
94.33%
-5.14M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
41.36M
9.29%
+189.52K
+0.46%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
23.15M
5.2%
+208.71K
+0.91%
Mar 31, 2025
State Street Global Advisors (US)
19.80M
4.45%
-46.05K
-0.23%
Mar 31, 2025
State Farm Insurance Companies
16.88M
3.79%
-120.91K
-0.71%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.99M
2.47%
+368.11K
+3.47%
Mar 31, 2025
Wellington Management Company, LLP
6.07M
1.36%
-893.17K
-12.84%
Mar 31, 2025
Polen Capital Management, LLC
8.80M
1.98%
+1.31M
+17.55%
Mar 31, 2025
Wells Fargo Advisors
6.01M
1.35%
+338.64K
+5.97%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
5.06M
1.14%
+52.40K
+1.05%
Dec 31, 2024
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
ProShares Pet Care ETF
9.75%
VanEck Agribusiness ETF
7.36%
VanEck Pharmaceutical ETF
6.02%
iShares U.S. Pharmaceuticals ETF
4.3%
SPDR S&P Pharmaceuticals ETF
3.89%
First Trust NASDAQ Pharmaceuticals ETF
3.78%
Honeytree US Equity ETF
3.55%
Polen Capital Global Growth ETF
3.35%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
3.16%
Jensen Quality Growth ETF
2.96%
查看更多
ProShares Pet Care ETF
占比9.75%
VanEck Agribusiness ETF
占比7.36%
VanEck Pharmaceutical ETF
占比6.02%
iShares U.S. Pharmaceuticals ETF
占比4.3%
SPDR S&P Pharmaceuticals ETF
占比3.89%
First Trust NASDAQ Pharmaceuticals ETF
占比3.78%
Honeytree US Equity ETF
占比3.55%
Polen Capital Global Growth ETF
占比3.35%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比3.16%
Jensen Quality Growth ETF
占比2.96%
分红派息
近5年累计派现
2.94B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
